| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 13.521 | 766 | 119 | 96 | 53 | 53 | 20 | 195 | 128 | 22 |
| Total Expenses - EUR | 33.126 | 2.135.224 | 312 | 92 | 248 | 192 | 139 | 194 | 168 | 222 |
| Gross Profit/Loss - EUR | -19.605 | -2.134.458 | -194 | 5 | -195 | -140 | -119 | 1 | -40 | -201 |
| Net Profit/Loss - EUR | -19.605 | -2.134.458 | -194 | 5 | -195 | -140 | -119 | 1 | -40 | -201 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharma Point Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.502.180 | 23.767 | 17.644 | 13.022 | 12.770 | 12.528 | 12.251 | 12.289 | 12.251 | 12.283 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 2.049.405 | 23.758 | 17.634 | 13.013 | 12.761 | 12.520 | 12.242 | 12.280 | 12.243 | 12.175 |
| Cash | 452.775 | 9 | 9 | 9 | 9 | 9 | 8 | 9 | 8 | 109 |
| Shareholders Funds | 2.042.797 | -112.450 | -110.741 | -108.704 | -106.794 | -104.909 | -102.702 | -103.019 | -102.748 | -102.375 |
| Social Capital | 45 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 459.817 | 136.218 | 128.385 | 121.726 | 119.564 | 117.437 | 114.952 | 115.308 | 115.000 | 114.658 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharma Point Srl